Breakthrough device aims to prevent deadly complications during common heart surgery

NCT ID NCT05666713

Completed Disease control Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Source: ClinicalTrials.gov ↗

Summary

This study tested a new medical device called TELLTALE, designed to make heart valve replacement surgery (TAVR) safer. The device helps doctors safely cut a small flap of heart tissue that can sometimes block blood flow during the procedure—a rare but often fatal complication. Researchers enrolled 90 high-risk patients to see if this purpose-built tool was effective and safe compared to older, improvised methods.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States
California Pacific Med Ctr

San Francisco, California, 94109, United States
Carilion Medical Center

Roanoke, Virginia, 24014, United States
Emory University

Atlanta, Georgia, 30308, United States
Medstar WHC

Washington D.C., District of Columbia, 20010, United States
Montefiore Medical Center

The Bronx, New York, 10467, United States
Rochester Regional Health

Rochester, New York, 14621, United States
St. Francis Hospital and Heart Center

Roslyn, New York, 11576, United States
University of Colorado Health

Fort Collins, Colorado, 80528, United States
University of Washington Heart Institute

Seattle, Washington, 98195, United States

Conditions

Explore the condition pages connected to this study.

AORTIC VALVE FAILURE VALVULAR HEART DISEASE